NeuroPace Inc (NeuroPace) is a commercial-stage medical device company that focuses on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its major product includes RNS System, is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes an RNS neurostimulator, cortical strip leads and depth leads and a Patient Remote Monitor, as well as other implantable and non-implantable accessories. NeuroPace is headquartered in Mountain View, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company NeuroPace Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- NeuroPace Inc Company Overview
- NeuroPace Inc Company Snapshot
- NeuroPace Inc Pipeline Products and Ongoing Clinical Trials Overview
- NeuroPace Inc - Pipeline Analysis Overview
- NeuroPace Inc - Key Facts
- NeuroPace Inc - Major Products and Services
- NeuroPace Inc Pipeline Products by Development Stage
- NeuroPace Inc Ongoing Clinical Trials by Trial Status
- NeuroPace Inc Pipeline Products Overview
- NeuroPace RNS System - Adolescents
- NeuroPace RNS System - Adolescents Product Overview
- NeuroPace RNS System - Idiopathic Generalized Epilepsy
- NeuroPace RNS System - Idiopathic Generalized Epilepsy Product Overview
- NeuroPace RNS System - Idiopathic Generalized Epilepsy Clinical Trial
- NeuroPace RNS System - Lennox Gastaut Syndrome
- NeuroPace RNS System - Lennox Gastaut Syndrome Product Overview
- NeuroPace Inc - Key Competitors
- NeuroPace Inc - Key Employees
- NeuroPace Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- NeuroPace Inc, Recent Developments
- Mar 05, 2024: NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
- Dec 21, 2023: NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study
- Dec 04, 2023: NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
- Dec 04, 2023: NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
- Oct 17, 2023: NeuroPace Announces RNS System Enhancements Designed to Streamline Care
- Jan 09, 2023: NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors
- Nov 30, 2022: NeuroPace feasibility study of Its RNS system for Lennox-Gastaut Syndrome now underway
- Oct 12, 2022: First patient implanted in NeuroPace’s RNS System trial for IGE
- Oct 11, 2022: NeuroPace Announces First Patient Implanted in NAUTILUS Pivotal Study for the Treatment of Idiopathic Generalized Epilepsy (IGE)
- Aug 23, 2022: NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- NeuroPace Inc Pipeline Products and Ongoing Clinical Trials Overview
- NeuroPace Inc Pipeline Products by Equipment Type
- NeuroPace Inc Pipeline Products by Indication
- NeuroPace Inc Ongoing Clinical Trials by Trial Status
- NeuroPace Inc, Key Facts
- NeuroPace Inc, Major Products and Services
- NeuroPace Inc Number of Pipeline Products by Development Stage
- NeuroPace Inc Pipeline Products Summary by Development Stage
- NeuroPace Inc Ongoing Clinical Trials by Trial Status
- NeuroPace Inc Ongoing Clinical Trials Summary
- NeuroPace RNS System - Adolescents - Product Status
- NeuroPace RNS System - Adolescents - Product Description
- NeuroPace RNS System - Idiopathic Generalized Epilepsy - Product Status
- NeuroPace RNS System - Idiopathic Generalized Epilepsy - Product Description
- NeuroPace RNS System - Idiopathic Generalized Epilepsy - Mapping Algorithmic State Space in the Human Brain
- NeuroPace RNS System - Idiopathic Generalized Epilepsy - RNS System NAUTILUS Study (NAUTILUS)
- NeuroPace RNS System - Lennox Gastaut Syndrome - Product Status
- NeuroPace RNS System - Lennox Gastaut Syndrome - Product Description
- NeuroPace Inc, Key Employees
- Glossary
- NeuroPace Inc Pipeline Products by Equipment Type
- NeuroPace Inc Pipeline Products by Development Stage
- NeuroPace Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- NexGen Medical Systems Inc
- Bracket Global LLC
- Synapse Biomedical Inc
- NeuroMEDx
- XLTEK
- NeuroPro Technologies Inc
- NeuroPro Technologies Inc
- NexGen Medical Systems Inc
- Bracket Global LLC
- Synapse Biomedical Inc
- NeuroMEDx
- XLTEK
